Skip to Content
Merck
  • Sustained lung inflation at birth for preterm infants: a randomized clinical trial.

Sustained lung inflation at birth for preterm infants: a randomized clinical trial.

Pediatrics (2015-01-28)
Gianluca Lista, Luca Boni, Fabio Scopesi, Fabio Mosca, Daniele Trevisanuto, Hubert Messner, Giovanni Vento, Rosario Magaldi, Antonio Del Vecchio, Massimo Agosti, Camilla Gizzi, Fabrizio Sandri, Paolo Biban, Massimo Bellettato, Diego Gazzolo, Antonio Boldrini, Carlo Dani
ABSTRACT

Studies suggest that giving newly born preterm infants sustained lung inflation (SLI) may decrease their need for mechanical ventilation (MV) and improve their respiratory outcomes. We randomly assigned infants born at 25 weeks 0 days to 28 weeks 6 days of gestation to receive SLI (25 cm H2O for 15 seconds) followed by nasal continuous positive airway pressure (nCPAP) or nCPAP alone in the delivery room. SLI and nCPAP were delivered by using a neonatal mask and a T-piece ventilator. The primary end point was the need for MV in the first 72 hours of life. The secondary end points included the need for respiratory supports and survival without bronchopulmonary dysplasia (BPD). A total of 148 infants were enrolled in the SLI group and 143 in the control group. Significantly fewer infants were ventilated in the first 72 hours of life in the SLI group (79 of 148 [53%]) than in the control group (93 of 143 [65%]); unadjusted odds ratio: 0.62 [95% confidence interval: 0.38-0.99]; P = .04). The need for respiratory support and survival without BPD did not differ between the groups. Pneumothorax occurred in 1% (n = 2) of infants in the control group compared with 6% (n = 9) in the SLI group, with an unadjusted odds ratio of 4.57 (95% confidence interval: 0.97-21.50; P = .06). SLI followed by nCPAP in the delivery room decreased the need for MV in the first 72 hours of life in preterm infants at high risk of respiratory distress syndrome compared with nCPAP alone but did not decrease the need for respiratory support and the occurrence of BPD.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Water, deuterium-depleted, ≤1 ppm (Deuterium oxide)
Supelco
Water, for TOC analysis
Supelco
Density Standard 998 kg/m3, H&D Fitzgerald Ltd. Quality
Sigma-Aldrich
Water, BioPerformance Certified
Supelco
Water, ACS reagent, for ultratrace analysis
Sigma-Aldrich
Water, tested according to Ph. Eur.
Supelco
Water, for HPCE, for luminescence, suitable for UV/Vis spectroscopy
Sigma-Aldrich
Water, for cell biology, sterile ultrafiltered
Sigma-Aldrich
Water, for embryo transfer, sterile-filtered, BioXtra, suitable for mouse embryo cell culture
Sigma-Aldrich
E-Toxate Water, endotoxin, free
Sigma-Aldrich
Water, PCR Reagent
Sigma-Aldrich
Water, sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
Water, Nuclease-Free Water, for Molecular Biology
Sigma-Aldrich
Water, for molecular biology, sterile filtered
Supelco
Water, suitable for ion chromatography
Pure Water Density Standard, UKAS ISO/IEC17025 and ISO Guide 34 certified, density: 0.9982 g/mL at 20 °C, density: 0.9970 g/mL at 25 °C
Pure Water Density Standard, UKAS ISO/IEC17025 and ISO Guide 34 certified, density: 0.9982 g/mL at 20 °C, density: 0.9970 g/mL at 25 °C
Sigma-Aldrich
Water, Deionized
Sigma-Aldrich
Water, ACS reagent
Sigma-Aldrich
Water, HPLC Plus
Sigma-Aldrich
Water, suitable for HPLC
Sigma-Aldrich
Water-16O, ≥99.94 atom % 16O